Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

August Sigle

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Nature Communications|January 30, 2025
Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growthYanhan Jia, Sheng Wang, Sylvia Urban, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2021
SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process MaintenanceManuel Rogg, Jasmin I Maier, Robert Dotzauer, et al.
Frontiers in Oncology|August 1, 2022
Intraindividual Comparison Between [<sup>18</sup>F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer PatientsIoana M Marinescu, Simon K B Spohn, Selina Kiefer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
European Urology Oncology|June 26, 2025
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?Giancarlo Marra, Geert J L H van Leenders, Guglielmo David, et al.
Science Advances|November 28, 2025
Arp2/3-dependent regulation of ciliogenesis governs adaptive distal tubular epithelial cell states in kidney diseaseManuel Rogg, Lisa Weißer, Jasmin I Maier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2020
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural NetworkDejan Kostyszyn, Tobias Fechter, Nico Bartl, et al.
European Urology Open Science|January 16, 2026
Impact of Negative Prostate-specific Membrane Antigen Positron Emission Tomography on the Decision to Perform a Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- to High-risk Prostate Cancer Patients: Results of an International SurveyFabio Zattoni, Pawel Rajwa, Veeru Kasivisvanathan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Nature Communications|January 30, 2025
Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growthYanhan Jia, Sheng Wang, Sylvia Urban, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2021
SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process MaintenanceManuel Rogg, Jasmin I Maier, Robert Dotzauer, et al.
Frontiers in Oncology|August 1, 2022
Intraindividual Comparison Between [<sup>18</sup>F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer PatientsIoana M Marinescu, Simon K B Spohn, Selina Kiefer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
European Urology Oncology|June 26, 2025
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?Giancarlo Marra, Geert J L H van Leenders, Guglielmo David, et al.
Science Advances|November 28, 2025
Arp2/3-dependent regulation of ciliogenesis governs adaptive distal tubular epithelial cell states in kidney diseaseManuel Rogg, Lisa Weißer, Jasmin I Maier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2020
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural NetworkDejan Kostyszyn, Tobias Fechter, Nico Bartl, et al.
European Urology Open Science|January 16, 2026
Impact of Negative Prostate-specific Membrane Antigen Positron Emission Tomography on the Decision to Perform a Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- to High-risk Prostate Cancer Patients: Results of an International SurveyFabio Zattoni, Pawel Rajwa, Veeru Kasivisvanathan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
Pageof 6